Medikaloka Hermina Financials
| HEAL Stock | IDR 1,515 35.00 2.36% |
Medikaloka |
Understanding current and past Medikaloka Hermina Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Medikaloka Hermina's financial statements are interrelated, with each one affecting the others. For example, an increase in Medikaloka Hermina's assets may result in an increase in income on the income statement.
Medikaloka Hermina Stock Summary
Medikaloka Hermina competes with Matahari Department, Surya Citra, and Lippo Karawaci. PT Medikaloka Hermina Tbk operates a network of general hospitals in Indonesia. The company was founded in 1999 and is based in Jakarta, Indonesia. Medikaloka Hermina operates under Medical Care Facilities classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 10547 people.| Foreign Associate | Canada |
| Instrument | Indonesia Stock View All |
| Exchange | Jakarta Exchange |
| ISIN | ID1000143100 |
| Business Address | Hermina Tower, Jakarta, |
| Sector | Health Care Providers & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.herminahospitals.com |
| Phone | 62 21 857 2525 |
| Currency | IDR - Indonesian Rupiah |
You should never invest in Medikaloka Hermina without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Medikaloka Stock, because this is throwing your money away. Analyzing the key information contained in Medikaloka Hermina's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Medikaloka Hermina Key Financial Ratios
Medikaloka Hermina's financial ratios allow both analysts and investors to convert raw data from Medikaloka Hermina's financial statements into concise, actionable information that can be used to evaluate the performance of Medikaloka Hermina over time and compare it to other companies across industries.| Return On Equity | 0.14 | |||
| Return On Asset | 0.0704 | |||
| Target Price | 1693.1 | |||
| Beta | 0.4 | |||
| Z Score | 9.0 |
Medikaloka Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medikaloka Hermina's current stock value. Our valuation model uses many indicators to compare Medikaloka Hermina value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medikaloka Hermina competition to find correlations between indicators driving Medikaloka Hermina's intrinsic value. More Info.Medikaloka Hermina PT is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.50 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medikaloka Hermina PT is roughly 1.99 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medikaloka Hermina's earnings, one of the primary drivers of an investment's value.Medikaloka Hermina Systematic Risk
Medikaloka Hermina's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Medikaloka Hermina volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Medikaloka Hermina correlated with the market. If Beta is less than 0 Medikaloka Hermina generally moves in the opposite direction as compared to the market. If Medikaloka Hermina Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Medikaloka Hermina is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Medikaloka Hermina is generally in the same direction as the market. If Beta > 1 Medikaloka Hermina moves generally in the same direction as, but more than the movement of the benchmark.
Medikaloka Hermina December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Medikaloka Hermina help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Medikaloka Hermina PT. We use our internally-developed statistical techniques to arrive at the intrinsic value of Medikaloka Hermina PT based on widely used predictive technical indicators. In general, we focus on analyzing Medikaloka Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Medikaloka Hermina's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.69 | |||
| Information Ratio | 0.051 | |||
| Maximum Drawdown | 9.14 | |||
| Value At Risk | (2.31) | |||
| Potential Upside | 3.77 |
Other Information on Investing in Medikaloka Stock
Medikaloka Hermina financial ratios help investors to determine whether Medikaloka Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medikaloka with respect to the benefits of owning Medikaloka Hermina security.